Bihormonal Patch Pump Control With Low-Input Glucose Response
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing infusion pump systems for diabetes treatment require high levels of cognitive engagement and user input, which impedes their acceptance and optimal blood sugar control.
Innovation Solution
The development of patch pumps with novel drive train concepts and glucagon pumps that respond to glucose level control signals, combined with third-party insulin delivery systems, featuring minimal user input and automated operation, including dual cannula, coaxial cannula, top/bottom cannula, and micro-needle arrays, and utilizing the iLET App for seamless insulin delivery.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If traditional infusion pump systems are used, then blood sugar control can be achieved, but high levels of cognitive engagement and user input are required which impedes acceptance
Solution Approach 1:
The patch pump system automatically monitors blood glucose levels through integrated sensors and delivers insulin without requiring user input or cognitive engagement. The system self-regulates by continuously monitoring and adjusting insulin delivery based on real-time glucose data, eliminating the need for user intervention in the control loop.
Solution Approach 2:
The system incorporates closed-loop feedback control where blood glucose sensors continuously monitor blood sugar levels, and the pump automatically adjusts insulin delivery based on this feedback. This closed-loop architecture eliminates the need for user cognitive engagement by automatically processing glucose data and adjusting medication delivery in real-time.
2Adaptability or versatility
If modular system components are implemented, then system versatility improves, but device complexity increases
Solution Approach 1:
The patch pump system is designed as a universal platform that can integrate with multiple third-party insulin delivery systems and glucose monitoring devices. The standardized interfaces and modular architecture allow the same pump unit to work with different cannula types, infusion sets, and monitoring systems, providing versatility without requiring multiple specialized devices.
Solution Approach 2:
The system is divided into modular components including the pump unit, sensor array, cannula assembly, and control algorithms, which can be independently selected and combined. This segmentation allows users to configure the system with specific components based on their needs while maintaining overall system simplicity through standardized connections.
3Productivity
If advanced drive train concepts are used, then pumping efficiency improves, but manufacturing complexity increases
Solution Approach 1:
The drive train mechanism merges multiple functions into a single integrated assembly where the motor, gear system, and cannula attachment are combined in one unit. This integration simplifies manufacturing by reducing the number of separate components that need to be assembled, while maintaining efficient medicament delivery through the consolidated mechanical design.
Data Source
AI summary
The new and future systems for low cognitive load disposable and durable medicament pumping systems now include at least one of pump embodiments for pairing of an APP in half-of a dozen embodiments respecting all known and to be installed features of the Beta Bionics (Irvine, CA patent estate and inchoate matters).